• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便钙卫蛋白在以腹痛为主要表现伴有或不伴有腹泻或直肠出血的患者就诊于急诊科中的作用。

Role of Fecal Calprotectin in Patients Presenting to the Emergency Department with Abdominal Pain with or without Diarrhea or Rectal Bleeding.

机构信息

Department of Emergency Medicine-Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

Department of Emergency Medicine-Ospedale San Carlo di Nancy GVM care and research, Rome, Italy.

出版信息

Rev Recent Clin Trials. 2024;19(1):70-75. doi: 10.2174/0115748871259008231006071656.

DOI:10.2174/0115748871259008231006071656
PMID:37921137
Abstract

BACKGROUND AND OBJECTIVE

Abdominal pain is a frequent reason for admission to the Emergency Department. It may be a symptom of an underlying "organic" disease or a "functional" manifestation without an underlying anatomic or physiologic alteration. The evaluation of patients with abdominal pain is a challenge for the emergency physician and the selection of patients for second-level radiological examinations or endoscopic procedures is not always easy to perform. Faecal calprotectin could be a useful diagnostic marker to distinguish between "organic" or "functional" form and its determination could be helpful to select patients for further examinations in the context of an emergency setting.

MATERIALS AND METHODS

This is an observational and retrospective study on 146 patients with abdominal pain and/or diarrhea (with or without rectal bleeding) admitted to the Emergency Department of Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, who collected a fecal sample to evaluate fecal calprotectin. We evaluated and correlated the level of fecal calprotectin with the final diagnosis they received.

RESULTS

50/146 patients (34,24%) received a diagnosis of acute diverticulitis, in particular, 14/50 (28%) were complicated and 36/50 (72%) were uncomplicated; 4/146 (2,7%) were cholangitis, 32/146 (21,9%) were colitis, 6/146 (4,1%) gastritis, 42/146 (28,7%), Irritable bowel syndrome and 12/146 (8,2%) Inflammatory bowel disease. For the differential diagnosis between Irriable or inflammatory bowel diseses, our study showed a VPP and a VPN of 100% meanwhile for the differential diagnosis between Acute complicated and uncomplicated diverticulitis, our study showed a VPP of 40% and a VPN of 84%.

CONCLUSION

In the emergency setting, faecal calprotectin could be a helpful marker to select patients with abdominal pain who need second-level radiological examinations or endoscopic procedures, guiding the emergency physician in the evaluation of such a complex and wideranging symptom.

摘要

背景与目的

腹痛是急诊科就诊的常见原因。它可能是潜在“器质性”疾病的症状,也可能是一种无潜在解剖或生理改变的“功能性”表现。对腹痛患者的评估对急诊医生来说是一个挑战,选择患者进行二级放射学检查或内镜检查并不总是容易做到的。粪便钙卫蛋白可能是区分“器质性”或“功能性”形式的有用诊断标志物,其测定有助于在急诊环境下选择需要进一步检查的患者。

材料与方法

这是一项对 146 例腹痛和/或腹泻(伴有或不伴有直肠出血)患者的观察性回顾性研究,这些患者在罗马的 Fondazione Policlinico Universitario A. Gemelli IRCCS 急诊科就诊时采集粪便样本以评估粪便钙卫蛋白。我们评估并将粪便钙卫蛋白的水平与他们最终诊断相关联。

结果

146 例患者中有 50 例(34.24%)被诊断为急性憩室炎,其中 14/50 例(28%)为复杂性,36/50 例(72%)为非复杂性;4/146 例(2.7%)为胆管炎,32/146 例(21.9%)为结肠炎,6/146 例(4.1%)为胃炎,42/146 例(28.7%)为肠易激综合征,12/146 例(8.2%)为炎症性肠病。为了区分肠易激或炎症性肠病,我们的研究显示其阳性预测值和阴性预测值均为 100%;而在区分急性复杂和非复杂性憩室炎时,我们的研究显示阳性预测值为 40%,阴性预测值为 84%。

结论

在急诊环境中,粪便钙卫蛋白可能是一种有用的标志物,可以选择需要进行二级放射学检查或内镜检查的腹痛患者,指导急诊医生评估这种复杂而广泛的症状。

相似文献

1
Role of Fecal Calprotectin in Patients Presenting to the Emergency Department with Abdominal Pain with or without Diarrhea or Rectal Bleeding.粪便钙卫蛋白在以腹痛为主要表现伴有或不伴有腹泻或直肠出血的患者就诊于急诊科中的作用。
Rev Recent Clin Trials. 2024;19(1):70-75. doi: 10.2174/0115748871259008231006071656.
2
Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.粪便钙卫蛋白测定在预测小肠影像学异常中的诊断准确性。
Aliment Pharmacol Ther. 2004 Sep 15;20(6):615-21. doi: 10.1111/j.1365-2036.2004.02128.x.
3
Clinical Significance of Faecal Calprotectin in Differentiating Inflammatory Bowel Disease from Irritable Bowel Syndrome.粪便钙卫蛋白在鉴别炎症性肠病与肠易激综合征中的临床意义。
Mymensingh Med J. 2024 Oct;33(4):1149-1156.
4
FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.粪便钙卫蛋白:巴西胃肠道症状患者病因诊断的水平
Arq Gastroenterol. 2015 Jan-Mar;52(1):50-4. doi: 10.1590/S0004-28032015000100011.
5
Moderate to severe and prolonged left lower-abdominal pain is the best symptom characterizing symptomatic uncomplicated diverticular disease of the colon: a comparison with fecal calprotectin in clinical setting.中重度且持续的左下腹疼痛是有症状的非复杂性结肠憩室病的最佳特征性症状:临床环境中与粪便钙卫蛋白的比较
J Clin Gastroenterol. 2015 Mar;49(3):218-21. doi: 10.1097/MCG.0000000000000094.
6
Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.粪便钙卫蛋白在评估腹痛患者中的价值:一项观察性研究。
BMC Gastroenterol. 2012 Jan 10;12:5. doi: 10.1186/1471-230X-12-5.
7
Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children.患有婴儿腹绞痛的婴儿、健康婴儿、炎症性肠病患儿、复发性腹痛患儿及健康儿童的粪便钙卫蛋白水平
Acta Paediatr. 2002;91(1):45-50. doi: 10.1080/080352502753457932.
8
Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.粪便钙卫蛋白是区分炎症性肠病和功能性胃肠疾病的有用标志物。
Gastroenterol Hepatol. 2017 Mar;40(3):125-131. doi: 10.1016/j.gastrohep.2016.04.009. Epub 2016 May 31.
9
Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.预测腹痛和腹泻儿童的炎症性肠病:钙粒蛋白-C 与钙卫蛋白粪便检测。
Arch Dis Child. 2018 Jun;103(6):565-571. doi: 10.1136/archdischild-2017-314081. Epub 2018 Mar 7.
10
[Fecal calprotectin in differential diagnosis of irritable bowel syndrome].[粪便钙卫蛋白在肠易激综合征鉴别诊断中的应用]
Beijing Da Xue Xue Bao Yi Xue Ban. 2006 Jun 18;38(3):310-3.

本文引用的文献

1
Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational Study.结肠镜检查正常的患者粪便钙卫蛋白升高:在临床实践中这重要吗?一项回顾性观察研究。
Inflamm Intest Dis. 2021 May;6(2):101-108. doi: 10.1159/000513473. Epub 2021 Feb 17.
2
The value of abdominal ultrasonography compared to colonoscopy and faecal calprotectin in following up paediatric patients with ulcerative colitis.与结肠镜检查和粪便钙卫蛋白相比,腹部超声在溃疡性结肠炎患儿随访中的价值。
Med Ultrason. 2021 May 20;23(2):153-160. doi: 10.11152/mu-3005. Epub 2021 Feb 1.
3
Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis.
粪便钙卫蛋白作为一种非侵入性的检测手段,用于预测溃疡性结肠炎患者的深度缓解。
Medicine (Baltimore). 2021 Jan 22;100(3):e24058. doi: 10.1097/MD.0000000000024058.
4
Clinical Spectrum in a Cohort of Patients With High Fecal Calprotectin Levels.高粪便钙卫蛋白水平患者队列的临床谱
Cureus. 2020 Nov 3;12(11):e11314. doi: 10.7759/cureus.11314.
5
Inpatient usage of faecal calprotectin in a tertiary hospital.一家三级医院粪便钙卫蛋白的住院患者使用情况
Intern Med J. 2022 Mar;52(3):436-439. doi: 10.1111/imj.15086.
6
Faecal Calprotectin.粪便钙卫蛋白
Clin Biochem Rev. 2018 Aug;39(3):77-90.
7
Epidemiology and outcomes of acute abdominal pain in a large urban Emergency Department: retrospective analysis of 5,340 cases.大型城市急诊科急性腹痛的流行病学及结局:5340例病例的回顾性分析
Ann Transl Med. 2016 Oct;4(19):362. doi: 10.21037/atm.2016.09.10.
8
Fecal calprotectin: can be used to distinguish between bacterial and viral gastroenteritis in children?粪便钙卫蛋白:可用于区分儿童细菌性和病毒性肠胃炎吗?
Am J Emerg Med. 2015 Oct;33(10):1436-9. doi: 10.1016/j.ajem.2015.07.007. Epub 2015 Jul 6.
9
A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease.粪便钙卫蛋白在静止期克罗恩病中预测价值的前瞻性评估。
J Crohns Colitis. 2014 Sep;8(9):1022-9. doi: 10.1016/j.crohns.2014.01.029. Epub 2014 Feb 22.
10
A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.一项关于静止期克罗恩病粪便钙卫蛋白个体内变异性的前瞻性单中心评估。
Aliment Pharmacol Ther. 2013 Mar;37(6):613-21. doi: 10.1111/apt.12221. Epub 2013 Jan 24.